Bayer Diagnostics launches its latest immunoassay system, part of
its ADVIA family of automated clinical laboratory solutions, which
enable laboratories to rapidly perform a wide variety of
disease-specific tests which enhance the...
An affirmation that aims to replace the use of laboratory animals
in testing was agreed in Brussels by key industry sectors
representing the European chemical, pharmaceutical and
biotechnology industries.
Cambrex has recorded a gain in the third quarter of this year, with
growth in its Bioproducts and Human Health segments. The company's
troublesome BioPharma division continues to underperform,
indicative of a market for outsourced...
Cardinal Health reported a varied first quarter, with sales and
income receiving substantial gains due to across-the-board
improvement in pharmaceutical distribution, medical products and
services and clinical technologies.
Genetic diagnostics is driving improvements in modern day medical
treatment with the move towards personalised medicine and
prevention-oriented healthcare all opening up market opportunities
for genetic pinpointing techniques.
Medisyn Technologies has entered into agreement with Humanetics
that aims to drive the discovery of natural compounds that can
offer safe, natural therapeutic options in the areas of obesity,
immune system and cognitive function.
Materials company, Micromuscle, has developed an electro-active
polymer technology that allows the controlled release of liquid
medications that reflect an emerging class of advanced materials
with new revolutionary properties.
S R Pharma have released its interim results for the first half of
2005, which show the continued consolidation of Research and
Development costs as resources were diverted to acquire contract
development services provider, Atugen.
Eisai has become the first Japanese drugmaker to set up a dedicated
subsidiary in India in order to tap into local expertise in
manufacturing and research, according to local press reports.
UK pharmaceutical testing company Cirrus Laboratories has been
acquired by Bodycote Materials Testing, an international provider
of materials testing services to industry.
Aegis Therapeutics announced it has entered into a licensing agreement for its patented Intravail drug delivery technology for application to several paediatric therapeutics.
UK pharmaceutical company ML Laboratories has acquired Quadrant
Technologies, a company specialising in drug formulation and
stabilisation, for £46.7 million (€70m), boosting its capabilities
in the development of inhaled medicines,...
The boundary between the pharma and biotech industries will become
incresingly blurred over the next 10 years, with the latter
enjoying stronger growth, writes Phil Taylor.
In-PharmaTechnologist.com presents a round up of personnel news in
the pharmaceutical sector, including the sudden departure of Susan
Vogt from Millipore.
Cardinal Health saw a double-digit hike in fiscal third quarter
revenues mirrored by a decline in operating earnings, as gains in
its drug distribution and medical products businesses were offset
by lower profits in sterile manufacturing...
The Association of the British Pharmaceutical Industry has praised
the latest report, acknowledging the importance of the UK
pharmaceutical industry in "improving people's quality of life,
reducing the need for surgical...
UK firm Denny Bros has introduced a new booklet-style label to the
pharma sector that incorporates a secondary, 'pealable' label that
can be used for administration or other functions.
According to a new report, the growth in molecular diagnostic
technologies is a driving factor leading major pharmaceutical
companies to incorporate a new category of medicine, theranostics,
into their drug development.
A new report identifies the nucleic acid (NA) therapeutic market to
reach over $210 billion (€161bn), illustrating a solid and
potentially very profitable approach to treatment of cancer,
rheumatoid arthritis, cardiovascular conditions,...
A study into the price of orphan drugs in the EU revealed that
access to treatments for patients with rare disorders can vary by
as much as 70 per cent within individual EU member states.
Bristol-Myers Squibb has announced the sudden death of James
Palmer, aged 51, the firm's chief scientific officer and
president of the Pharmaceutical Research Institute. His death
occurred after undergoing surgery. Elliot Sigal,...
Pharmaceutical company Mayne Pharma has entered into a unique
relationship with Birmingham's Aston University to create a
cleanroom for aseptic production that could improve the delivery of
drugs to the UK National Health Service...
Engineering firm AK Pharmaceuticals is to open a new Engineering
Centre of Excellence in Ireland, in a move that reaffirms the
healthy position of the Irish pharmaceutical industry. The move is
set to create 220 new jobs over the...
Medicated chewing gum company Fertin has launched its Chlorhexidine
therapeutic chewing gum in Singapore, the second chewing gum brand
approved since the country's relaxation of its chewing gum ban.
A collaboration agreement to identify and develop an improved
variant of CT500, a non-antibody protein with antagonist activity
against HMGB1 has been established, paving the way for
applications, to treat tumours and autoimmune diseases.
Affymetrix, a specialist in chip-based laboratory tools, has
launched what it claims is the world's first microarray instrument
system for clinical diagnostics.
US-based healthcare conglomerate Cardinal Health has stepped up its
presence in the European market with the appointment of a new
management team for the region based in the UK.
UK-based packaging company Rexam has provided further evidence of
its commitment to the pharmaceutical sector with the purchase of
Plastic Omnium Medical, a company specialising in plastic
components for medical devices.
The UK government has promised to protect the large funding
increases for science announced in the country's last Spending
Review and pledged more investment under a new 10-year strategy for
science.
Researchers in the US have developed a way of making synthetic
polyketides - structures which form the backbone of a number of
drugs for cancer and infectious diseases - that could provide a new
route to the design of new medicines.
Cypak, a Swedish company specialising in novel forms of packaging,
has signed what promises to be a major new deal for a 'smart'
blister pack system that can detect if patient is taking medication
as prescribed.
US packaging specialist Advantek has sold its Vaculok range of
vacuum-insulated panels to MOCON, an instrumentation company
serving the medical, pharmaceutical and food industries.
Scottish start-up PharmaImaging will begin providing gamma
scintigraphy imaging services to companies involved in Phase I drug
development in early 2004, with PET facilities coming on-line later
that year.
Misssouri-based medical genomics company GenoMed will link up with
Malaysian company PhenoMed, encouraged by the Malaysian government
currently keen to push biotechnology advances in the country.
US life science chemicals company Cambrex has altered the terms of
its agreement to sell Rutherford Chemicals and will make a slightly
higher loss on the new transaction.
US pharmaceuticals major Pfizer is considering moving some of its
activities in Germany to the UK due to government health reforms;
meanwhile, Merck & Co has shelved plans to open a new R&D
facility in the country.
A fluorescence imaging technology developed by Siemens promises to
improve the in vivo imaging of molecular processes in drug
discovery and disease research
Cambrex plans to sell off its Rutherford Chemicals business for $64
million (€56m) to allow it to focus on its human health and
biosciences activities.
The Karolinska Institute, together with the Swedish academy of
pharmaceutical sciences, is organising BioTech Forum 2003, to take
place from 26 to 28 November in Stockholm, Sweden.
Australia's Biotechnology Frontiers is awarded a A$780,000 grant to
develop a microbiological quality control tool that can be used in
the pharma and food industries.
Microbiology specialist Biotrace has continued its expansion into
the healthcare sector with the acquisition of Denmark's Maltec,
helping it to target Scandinavia's strong pharma sector
For the first time, German chemicals and pharmaceuticals major
Bayer is offering a range of products and services from its
biotechnology division to third-party customers
A conference on 1 July will provide an update on the UK Medicines
and Healthcare products Regulatory Agency Best Practice Guidance on
the Labelling and Packaging of Medicines
